| Product Code: ETC8888236 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Portugal Malaria Vaccine Market Overview |
3.1 Portugal Country Macro Economic Indicators |
3.2 Portugal Malaria Vaccine Market Revenues & Volume, 2021 & 2031F |
3.3 Portugal Malaria Vaccine Market - Industry Life Cycle |
3.4 Portugal Malaria Vaccine Market - Porter's Five Forces |
3.5 Portugal Malaria Vaccine Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Portugal Malaria Vaccine Market Revenues & Volume Share, By Agent, 2021 & 2031F |
3.7 Portugal Malaria Vaccine Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.8 Portugal Malaria Vaccine Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Portugal Malaria Vaccine Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of malaria in Portugal |
4.2.2 Government initiatives to control and eradicate malaria |
4.2.3 Technological advancements in vaccine development |
4.2.4 Growing awareness about the importance of malaria vaccination |
4.3 Market Restraints |
4.3.1 High cost of vaccine development and distribution |
4.3.2 Regulatory challenges in vaccine approval process |
4.3.3 Limited access to healthcare in remote areas |
4.3.4 Concerns about vaccine safety and efficacy |
5 Portugal Malaria Vaccine Market Trends |
6 Portugal Malaria Vaccine Market, By Types |
6.1 Portugal Malaria Vaccine Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Portugal Malaria Vaccine Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Portugal Malaria Vaccine Market Revenues & Volume, By Pre-Erythrocytic Vaccine, 2021- 2031F |
6.1.4 Portugal Malaria Vaccine Market Revenues & Volume, By Erythrocytic Vaccine, 2021- 2031F |
6.1.5 Portugal Malaria Vaccine Market Revenues & Volume, By Multi-Antigen Vaccine, 2021- 2031F |
6.2 Portugal Malaria Vaccine Market, By Agent |
6.2.1 Overview and Analysis |
6.2.2 Portugal Malaria Vaccine Market Revenues & Volume, By Plasmodium Falciparum, 2021- 2031F |
6.2.3 Portugal Malaria Vaccine Market Revenues & Volume, By Plasmodium Vivax, 2021- 2031F |
6.2.4 Portugal Malaria Vaccine Market Revenues & Volume, By Anopheles Species, 2021- 2031F |
6.3 Portugal Malaria Vaccine Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 Portugal Malaria Vaccine Market Revenues & Volume, By Intramuscular, 2021- 2031F |
6.3.3 Portugal Malaria Vaccine Market Revenues & Volume, By Subcutaneous, 2021- 2031F |
6.3.4 Portugal Malaria Vaccine Market Revenues & Volume, By Intradermal, 2021- 2031F |
6.4 Portugal Malaria Vaccine Market, By Distribution Channel |
6.4.1 Overview and Analysis |
6.4.2 Portugal Malaria Vaccine Market Revenues & Volume, By NGO/Non-Profit Organization, 2021- 2031F |
6.4.3 Portugal Malaria Vaccine Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.4.4 Portugal Malaria Vaccine Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.4.5 Portugal Malaria Vaccine Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
7 Portugal Malaria Vaccine Market Import-Export Trade Statistics |
7.1 Portugal Malaria Vaccine Market Export to Major Countries |
7.2 Portugal Malaria Vaccine Market Imports from Major Countries |
8 Portugal Malaria Vaccine Market Key Performance Indicators |
8.1 Number of reported malaria cases in Portugal |
8.2 Percentage of population vaccinated against malaria |
8.3 Research and development investment in malaria vaccines |
8.4 Public health campaigns promoting malaria vaccination |
8.5 Accessibility of malaria vaccines in rural areas |
9 Portugal Malaria Vaccine Market - Opportunity Assessment |
9.1 Portugal Malaria Vaccine Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Portugal Malaria Vaccine Market Opportunity Assessment, By Agent, 2021 & 2031F |
9.3 Portugal Malaria Vaccine Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.4 Portugal Malaria Vaccine Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Portugal Malaria Vaccine Market - Competitive Landscape |
10.1 Portugal Malaria Vaccine Market Revenue Share, By Companies, 2024 |
10.2 Portugal Malaria Vaccine Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here